Business Strategy & Leadership

Diversity in leadership and boards: a checklist for biotech companies

We review key considerations for biotech companies to ensure diverse representation in leadership and boards.

5 Market Research Trends Showcased at TMRE 2020

报告：通过大流行金博宝188备用地址的制药合作和交易

This Informa report explores how partnering and deal-making in the pharma industry has been impacted by COVID-19.

Biopharma Partnering and Financing Trends, H1 2020

With the help of Biomedtracker, analysts at Pharma Intelligence have taken a deep dive into the worldwide biopharma industry partnership and financial dealmaking during the first halves of 2019 and 2020. What they found is astounding and inside the new white paper.

Biotech Startups: How to Succeed in a COVID-19 World

Taking a biotech company from concept, through clinical trials, and ultimately to market requires a perfect storm of good science, a sound investment, and the right management. This ebook is here to guide startups through this journey.

采访：促进中国与英国生命科学部门的繁荣

In this exclusive interview, Her Majesty’s Trade Commissioner for China at the Department for International Trade, John Edwards, discusses how China’s healthcare and life sciences markets are growing rapidly and are driven by increased demand and changes to regulations, plus much more.

Best of Both Worlds - Agile Lite + Check-ins Yield Winning Products

Video Interview - Johnson & Johnson’s approach to external innovation

William N. Hait, MD, PhD, Global Head at Johnson & Johnson External Innovation gives an exclusive interview to Lucie Ellis, Executive Editor of In Vivo, Pharma Intelligence, ahead of ChinaBio® Partnering Forum Digital.

采访 - j＆j对生命科学创新，伙伴关系和先进技术的多管途径方法

Dr. Dan Wang, Head, Johnson & Johnson Innovation, Asia Pacific, and Dr. Sharon Chan, Head of JLABS @ Shanghai discuss its support of startups, interests in diverse disease areas, the importance of collaborations and much more in this exclusive interview with EBD Group.

Top Biotech Deals in China

Discover the deals transforming China biotech! More than $12 billion in biopharma financing, alliances, IPOs, and new funds have been generated so far this year in China. Learn the details of these deals when you read this new free infographic.

Interview- Roche’s approach to drug discovery, innovation and meeting patients' needs

罗氏全球主管詹姆斯•Sabry Pharma Partnering, discusses Roche’s approach to discovering scientific breakthroughs, accelerating innovative research, collaborating with stakeholders, and meeting unmet medical needs in China and around the world.

为什么消费者继续寻找一个相信的理由

Insourcing vs outsourcing in cell and gene therapy manufacturing - WHITEPAPER

This whitepaper presents best practices for planning an outsourcing or insourcing strategy for manufacturing cell and gene therapies.

Giving a Pharma Giant a Tech Startup Makeover

This shows how we’re using data and digital to reimagining medicine. If successful, this could open up the entire area of digital therapeutics.

Biotech VC Down 20% in US as Policies Drive Away Foreign Investors, BIO Says

Bio的大卫托马斯表示，对美国国家安全监管的改革促使外国投资者并将Biotech空间的VC投资降低到20％。

Pharma embraces biopartnering at BIO-Europe to address its innovation deficit

Big Pharma对早期临床前资产的胃口持续增长，现在代表了最优惠和最大总额的发展阶段。因此，越来越多的学术机构正在借机会在生物欧洲的学术曲目中展示他们的努力。

Bruce L. Levine is a man you can thank for your future cell therapy

How Life Science Cares is fighting poverty in Boston

Life Science Cares is a collective industry effort that works across companies in the Boston area to fight poverty in the community. Executive Director Sarah MacDonald explains how.

BIO Report: Biotech hits highs in 2018, shakes off October stock sell-off

Lundbeck's new CEO discusses the company's road ahead in CNS research